In a study recently published in Frontiers in Immunology, Dr. Ziaur Rahman linked molecules called TLR7 and type II interferon to impairing the ability of immune cells to do their job. Dr. Rahman’s research and findings were supported by the Lupus Research Alliance.
Lupus is an autoimmune disease that affects an estimated 1.5 million Americans and close to 5 million people worldwide.
These exciting findings support further development by several companies of potential new lupus treatments that block these molecules. You can read more about the findings here.
Proposal Central by Altum helps organizations like the Lupus Research Alliance unlock the full potential of their funding efforts and deliver outcomes that benefit humanity faster.